Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Alan Thompson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Anatomy

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tozer D J; Marongiu G; Swanton J K; Thompson A J; Miller D H
Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis.
Bodini Benedetta; Khaleeli Zhaleh; Cercignani Mara; Miller David H; Thompson Alan J; Ciccarelli Olga
Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.
Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller D H; Montalban X; Polman C; Rocca M A; Thompson A J; Yousry T A; Filippi M
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Alan Thompson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tozer D J; Marongiu G; Swanton J K; Thompson A J; Miller D H
Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis.
Journal of magnetic resonance imaging : JMRI 2009;30(3):506-13.
2009: Bodini Benedetta; Khaleeli Zhaleh; Cercignani Mara; Miller David H; Thompson Alan J; Ciccarelli Olga
Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.
Human brain mapping 2009;30(9):2852-61.
2009: Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller D H; Montalban X; Polman C; Rocca M A; Thompson A J; Yousry T A; Filippi M
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
Neurology 2009;72(19):1693-701.
2009: Kolappan Madhan; Henderson Andrew P D; Jenkins Thomas M; Wheeler-Kingshott Claudia A M; Plant Gordon T; Thompson Alan J; Miller David H
Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.
Journal of neurology 2009;256(3):305-19.
2009: Swanton J K; Fernando K T; Dalton C M; Miszkiel K A; Altmann D R; Plant G T; Thompson A J; Miller D H
Early MRI in optic neuritis: the risk for disability.
Neurology 2009;72(6):542-50.
2009: Ciccarelli Olga; Behrens Timothy E; Johansen-Berg Heidi; Talbot Kevin; Orrell Richard W; Howard Robin S; Nunes Rita G; Miller David H; Matthews Paul M; Thompson Alan J; Smith Stephen M
Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics.
Human brain mapping 2009;30(2):615-24.
2009: van der Linden Femke A H; Kragt Jolijn J; Hobart Jeremy C; Klein Martin; Thompson Alan J; van der Ploeg Henk M; Polman Chris H; Uitdehaag Bernard M J
The size of the treatment effect: do patients and proxies agree?
BMC neurology 2009;9():12.
2008: Thompson Alan J
Multiple sclerosis--a global disorder and still poorly managed.
Lancet neurology 2008;7(12):1078-9.
2008: Khaleeli Zhaleh; Altmann Daniel R; Cercignani Mara; Ciccarelli Olga; Miller David H; Thompson Alan J
Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.
Archives of neurology 2008;65(11):1454-9.
2008: Fisniku Leonora K; Chard Declan T; Jackson Jonathan S; Anderson Valerie M; Altmann Daniel R; Miszkiel Katherine A; Thompson Alan J; Miller David H
Gray matter atrophy is related to long-term disability in multiple sclerosis.
Annals of neurology 2008;64(3):247-54.
2008: Rovaris Marco; Judica Elda; Sastre-Garriga Jaume; Rovira Alex; Sormani Maria Pia; Benedetti Beatrice; Korteweg Tijmen; De Stefano Nicola; Khaleeli Zhaleh; Montalban Xavier; Barkhof Frederik; Miller David H; Polman Chris; Thompson Alan J; Filippi Massimo
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(4):455-64.
2008: Jenkins T M; Khaleeli Z; Thompson A J
Diagnosis and management of primary progressive multiple sclerosis.
Minerva medica 2008;99(2):141-55.
2008: Fisniku L K; Brex P A; Altmann D R; Miszkiel K A; Benton C E; Lanyon R; Thompson A J; Miller D H
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
Brain : a journal of neurology 2008;131(Pt 3):808-17.
2008: Kragt J J; Thompson A J; Montalban X; Tintoré M; Río J; Polman C H; Uitdehaag B M J
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
Neurology 2008;70(13 Pt 2):1084-91.
2008: Cano Stefan J; Warner Thomas T; Thompson Alan J; Bhatia Kailash P; Fitzpatrick Ray; Hobart Jeremy C
The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?
Health and quality of life outcomes 2008;6():58.
2008: van der Linden Femke A H; Kragt Jolijn J; van Bon Margarethe; Klein Martin; Thompson Alan J; van der Ploeg Henk M; Polman Chris H; Uitdehaag Bernard M J
Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years.
BMC neurology 2008;8():2.
2007: Hobart Jeremy C; Cano Stefan J; Zajicek John P; Thompson Alan J
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations.
Lancet neurology 2007;6(12):1094-105.
2007: Khaleeli Z; Sastre-Garriga J; Ciccarelli O; Miller D H; Thompson A J
Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2007;78(10):1076-82.
2007: Ciccarelli O; Wheeler-Kingshott C A; McLean M A; Cercignani M; Wimpey K; Miller D H; Thompson A J
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis.
Brain : a journal of neurology 2007;130(Pt 8):2220-31.
2007: Swanton Josephine K; Rovira Alex; Tintore Mar; Altmann Daniel R; Barkhof Frederik; Filippi Massimo; Huerga Elena; Miszkiel Katherine A; Plant Gordon T; Polman Chris; Rovaris Marco; Thompson Alan J; Montalban Xavier; Miller David H
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.
Lancet neurology 2007;6(8):677-86.
2007: Khaleeli Z; Cercignani M; Audoin B; Ciccarelli O; Miller D H; Thompson A J
Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.
NeuroImage 2007;37(1):253-61.
2007: Trip S A; Schlottmann P G; Jones S J; Li W-Y; Garway-Heath D F; Thompson A J; Plant G T; Miller D H
Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(7):875-9.
2007: Jenkins Thomas M; Thompson Alan J
GPs have pivotal role in managing MS.
The Practitioner 2007;251(1694):37-40, 42-3, 46 passim.
2007: Audoin B; Davies G; Rashid W; Fisniku L; Thompson A J; Miller D H
Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(4):483-9.
2007: Rashid W; Davies G R; Chard D T; Griffin C M; Altmann D R; Thompson A J; Miller D H
Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(2):178-85.
2007: Davies G R; Hadjiprocopis A; Altmann D R; Chard D T; Griffin C M; Rashid W; Parker G J; Tofts P S; Kapoor R; Thompson A J; Miller D H
Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(2):169-77.
2007: Ward Nick S; Newton Jennifer M; Swayne Orlando B C; Lee Lucy; Frackowiak Richard S J; Thompson Alan J; Greenwood Richard J; Rothwell John C
The relationship between brain activity and peak grip force is modulated by corticospinal system integrity after subcortical stroke.
The European journal of neuroscience 2007;25(6):1865-73.
2007: Manfredonia Francesco; Ciccarelli Olga; Khaleeli Zhaleh; Tozer Daniel J; Sastre-Garriga Jaume; Miller David H; Thompson Alan J
Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis.
Archives of neurology 2007;64(3):411-5.
2007: Cano Stefan J; Thompson Alan J; Bhatia Khailash; Fitzpatrick Ray; Warner Thomas T; Hobart Jeremy C
Evidence-based guidelines for using the Short Form 36 in cervical dystonia.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):122-6.
2006: Cano S J; Hobart J C; Edwards M; Fitzpatrick R; Bhatia K; Thompson A J; Warner T T
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
Neurology 2006;67(12):2230-2.
2006: Cano S J; O'Connor R J; Thompson A J; Hobart J C
Exploring disability rating scale responsiveness II: do more response options help?
Neurology 2006;67(11):2056-9.
2006: Holland A; O'Connor R J; Thompson A J; Playford E D; Hobart J C
Talking the talk on walking the walk: a 12-item generic walking scale suitable for neurological conditions?
Journal of neurology 2006;253(12):1594-602.
2006: Audoin Bertrand; Davies Gerard R; Finisku Leonara; Chard Declan T; Thompson Alan J; Miller David H
Localization of grey matter atrophy in early RRMS : A longitudinal study.
Journal of neurology 2006;253(11):1495-501.
2006: van der Linden F A H; Kragt J J; Hobart J C; Klein M; Thompson A J; van der Ploeg H M; Polman C H; Uitdehaag B M J
Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life.
Journal of neurology, neurosurgery, and psychiatry 2006;77(10):1157-62.
2006: Ward Nick S; Brown Martin M; Thompson Alan J; Frackowiak Richard S J
Longitudinal changes in cerebral response to proprioceptive input in individual patients after stroke: an FMRI study.
Neurorehabilitation and neural repair 2006;20(3):398-405.
2006: Bieniek M; Altmann D R; Davies G R; Ingle G T; Rashid W; Sastre-Garriga J; Thompson A J; Miller D H
Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2006;77(9):1036-9.
2006: Swanton J K; Fernando K; Dalton C M; Miszkiel K A; Thompson A J; Plant G T; Miller D H
Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison.
Journal of neurology, neurosurgery, and psychiatry 2006;77(9):1070-2.
2006: Trip S A; Schlottmann P G; Jones S J; Garway-Heath D F; Thompson A J; Plant G T; Miller D H
Quantification of optic nerve head topography in optic neuritis: a pilot study.
The British journal of ophthalmology 2006;90(9):1128-31.
2006: Ciccarelli O; Behrens T E; Altmann D R; Orrell R W; Howard R S; Johansen-Berg H; Miller D H; Matthews P M; Thompson A J
Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis.
Brain : a journal of neurology 2006;129(Pt 7):1859-71.
2006: Ciccarelli O; Toosy A T; Marsden J F; Wheeler-Kingshott C M; Miller D H; Matthews P M; Thompson A J
Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis.
Journal of neurology 2006;253(7):882-91.
2006: Karrenbauer Virginija Danylaité; Leoni Valerio; Lim Ee Tuan; Giovannoni Gavin; Ingle Gordon T; Sastre-Garriga Jaume; Thompson Alan J; Rashid Waqar; Davies Gerard; Miller David H; Björkhem Ingemar; Masterman Thomas
Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.
Clinical neurology and neurosurgery 2006;108(5):456-60.
2006: Swanton J K; Fernando K; Dalton C M; Miszkiel K A; Thompson A J; Plant G T; Miller D H
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes.
Journal of neurology, neurosurgery, and psychiatry 2006;77(7):830-3.
2006: Trip S Anand; Schlottmann Patricio G; Jones Stephen J; Li Wai-Yung; Garway-Heath David F; Thompson Alan J; Plant Gordon T; Miller David H
Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy.
NeuroImage 2006;31(1):286-93.
2006: Ramdharry G M; Marsden J F; Day B L; Thompson A J
De-stabilizing and training effects of foot orthoses in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(2):219-26.
2006: Rashid Waqar; Davies Gerard R; Chard Declan T; Griffin Colette M; Altmann Dan R; Gordon Ros; Kapoor Raju; Thompson Alan J; Miller David H
Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size.
Journal of magnetic resonance imaging : JMRI 2006;23(4):473-6.
2006: Audoin Bertrand; Fernando Kryshani T M; Swanton Josephine K; Thompson Alan J; Plant Gordon T; Miller David H
Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis.
Brain : a journal of neurology 2006;129(Pt 4):1031-9.
2006: Trip S Anand; Wheeler-Kingshott Claudia; Jones Stephen J; Li Wai-Yung; Barker Gareth J; Thompson Alan J; Plant Gordon T; Miller David H
Optic nerve diffusion tensor imaging in optic neuritis.
NeuroImage 2006;30(2):498-505.
2006: Ward Nick S; Newton Jennifer M; Swayne Orlando B C; Lee Lucy; Thompson Alan J; Greenwood Richard J; Rothwell John C; Frackowiak Richard S J
Motor system activation after subcortical stroke depends on corticospinal system integrity.
Brain : a journal of neurology 2006;129(Pt 3):809-19.
2006: Tiberio M; Chard D T; Altmann D R; Davies G; Griffin C M; McLean M A; Rashid W; Sastre-Garriga J; Thompson A J; Miller D H
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Journal of neurology 2006;253(2):224-30.
2006: Rashid W; Davies G R; Chard D T; Griffin C M; Altmann D R; Gordon R; Thompson A J; Miller D H
Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study.
Journal of neurology, neurosurgery, and psychiatry 2006;77(1):51-5.
2006: Ramió-Torrentà L; Sastre-Garriga J; Ingle G T; Davies G R; Ameen V; Miller D H; Thompson A J
Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study.
Journal of neurology, neurosurgery, and psychiatry 2006;77(1):40-5.
2006: Hobart J C; Riazi A; Thompson A J; Styles I M; Ingram W; Vickery P J; Warner M; Fox P J; Zajicek J P
Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
Brain : a journal of neurology 2006;129(Pt 1):224-34.
2005: Zajicek J P; Sanders H P; Wright D E; Vickery P J; Ingram W M; Reilly S M; Nunn A J; Teare L J; Fox P J; Thompson A J
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Journal of neurology, neurosurgery, and psychiatry 2005;76(12):1664-9.
2005: Polman Chris H; Reingold Stephen C; Edan Gilles; Filippi Massimo; Hartung Hans-Peter; Kappos Ludwig; Lublin Fred D; Metz Luanne M; McFarland Henry F; O'Connor Paul W; Sandberg-Wollheim Magnhild; Thompson Alan J; Weinshenker Brian G; Wolinsky Jerry S
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
Annals of neurology 2005;58(6):840-6.
2005: Fernando K T M; Tozer D J; Miszkiel K A; Gordon R M; Swanton J K; Dalton C M; Barker G J; Plant G T; Thompson A J; Miller D H
Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.
Brain : a journal of neurology 2005;128(Pt 12):2911-25.
2005: Camp S J; Stevenson V L; Thompson A J; Ingle G T; Miller D H; Borras C; Brochet B; Dousset V; Falautano M; Filippi M; Kalkers N F; Montalban X; Polman C H; Langdon D W
A longitudinal study of cognition in primary progressive multiple sclerosis.
Brain : a journal of neurology 2005;128(Pt 12):2891-8.
2005: Sormani Maria Pia; Bruzzi Paolo; Beckmann Karola; Kappos Ludwig; Miller David H; Polman Chris; Pozzilli Carlo; Thompson Alan J; Wagner Klaus; Filippi Massimo
The distribution of magnetic resonance imaging response to interferonbeta-1b in multiple sclerosis.
Journal of neurology 2005;252(12):1455-8.
2005: Hobart J C; Riazi A; Lamping D L; Fitzpatrick R; Thompson A J
How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales.
Journal of neurology, neurosurgery, and psychiatry 2005;76(11):1539-43.
2005: Ingle G T; Sastre-Garriga J; Miller D H; Thompson A J
Is inflammation important in early PPMS? a longitudinal MRI study.
Journal of neurology, neurosurgery, and psychiatry 2005;76(9):1255-8.
2005: Trip S Anand; Schlottmann Patricio G; Jones Stephen J; Altmann Daniel R; Garway-Heath David F; Thompson Alan J; Plant Gordon T; Miller David H
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.
Annals of neurology 2005;58(3):383-91.
2005: Ciccarelli O; Toosy A T; Marsden J F; Wheeler-Kingshott C M; Sahyoun C; Matthews P M; Miller D H; Thompson A J
Identifying brain regions for integrative sensorimotor processing with ankle movements.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 2005;166(1):31-42.
2005: Davies G R; Altmann D R; Hadjiprocopis A; Rashid W; Chard D T; Griffin C M; Tofts P S; Barker G J; Kapoor R; Thompson A J; Miller D H
Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.
Journal of neurology 2005;252(9):1037-44.
2005: Sastre-Garriga J; Ingle G T; Rovaris M; Téllez N; Jasperse B; Altmann D R; Benedetti B; Stevenson V L; Cercignani M; Leary S M; Barkhof F; Brochet B; Dousset V; Filippi M; Montalban X; Kalkers N F; Polman C H; Rovira A; Miller D H; Thompson A J
Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data.
Neurology 2005;65(4):633-5.
2005: O'Connor Rory J; Cano Stefan J; Ramió i Torrentà Lluis; Thompson Alan J; Playford E Diane
Factors influencing work retention for people with multiple sclerosis: cross-sectional studies using qualitative and quantitative methods.
Journal of neurology 2005;252(8):892-6.
2005: Ciccarelli Olga; Toosy Ahmed T; Hickman Simon J; Parker Geoff J M; Wheeler-Kingshott Claudia A M; Miller David H; Thompson Alan J
Optic radiation changes after optic neuritis detected by tractography-based group mapping.
Human brain mapping 2005;25(3):308-16.
2005: O'Connor Rory J; Cano Stefan J; Thompson Alan J; Playford E Diane
The impact of inpatient neurorehabilitation on psychological well-being on discharge and at 3 month follow-up.
Journal of neurology 2005;252(7):814-9.
2005: Davies G R; Altmann D R; Rashid W; Chard D T; Griffin C M; Barker G J; Kapoor R; Thompson A J; Miller D H
Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(3):276-81.
2005: Thompson Alan J
Neurorehabilitation in multiple sclerosis: foundations, facts and fiction.
Current opinion in neurology 2005;18(3):267-71.
2005: Sastre-Garriga Jaume; Ingle Gordon T; Chard Declan T; Cercignani Mara; Ramió-Torrentà Lluís; Miller David H; Thompson Alan J
Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
Brain : a journal of neurology 2005;128(Pt 6):1454-60.
2005: Toosy Ahmed T; Hickman Simon J; Miszkiel Katherine A; Jones Stephen J; Plant Gordon T; Altmann Daniel R; Barker Gareth J; Miller David H; Thompson Alan J
Adaptive cortical plasticity in higher visual areas after acute optic neuritis.
Annals of neurology 2005;57(5):622-33.
2005: Freeman J A; Hobart J C; Playford E D; Undy B; Thompson A J
Evaluating neurorehabilitation: lessons from routine data collection.
Journal of neurology, neurosurgery, and psychiatry 2005;76(5):723-8.
2005: Sastre-Garriga J; Ingle G T; Chard D T; Ramió-Torrentà Lí; McLean M A; Miller D H; Thompson A J
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
Archives of neurology 2005;62(4):569-73.
2005: Thompson A J; Jarrett L; Lockley L; Marsden J; Stevenson V L
Clinical management of spasticity.
Journal of neurology, neurosurgery, and psychiatry 2005;76(4):459-63.
2005: Tiberio M; Chard D T; Altmann D R; Davies G; Griffin C M; Rashid W; Sastre-Garriga J; Thompson A J; Miller D H
Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.
Neurology 2005;64(6):1001-7.
2005: Polman C H; Kappos L; Dahlke F; Graf R; Beckmann K; Bogumil T; Pozzilli C; Thompson A J;
Interferon beta-1b treatment does not induce autoantibodies.
Neurology 2005;64(6):996-1000.
2005: Cook P A; Zhang H; Avants B B; Yushkevich P; Alexander D C; Gee J C; Ciccarelli O; Thompson A J
An automated approach to connectivity-based partitioning of brain structures.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2005;8(Pt 1):164-71.
2005: Leary Siobhan M; Thompson Alan J
Primary progressive multiple sclerosis : current and future treatment options.
CNS drugs 2005;19(5):369-76.
2004: Davies G R; Tozer D J; Cercignani M; Ramani A; Dalton C M; Thompson A J; Barker G J; Tofts P S; Miller D H
Estimation of the macromolecular proton fraction and bound pool T2 in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):607-13.
2004: Serrien Deborah J; Strens Lucy H A; Cassidy Michael J; Thompson Alan J; Brown Peter
Functional significance of the ipsilateral hemisphere during movement of the affected hand after stroke.
Experimental neurology 2004;190(2):425-32.
2004: Kappos L; Weinshenker B; Pozzilli C; Thompson A J; Dahlke F; Beckmann K; Polman C; McFarland H;
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Neurology 2004;63(10):1779-87.
2004: Cano S J; Warner T T; Linacre J M; Bhatia K P; Thompson A J; Fitzpatrick R; Hobart J C
Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58).
Neurology 2004;63(9):1629-33.
2004: Hickman Simon J; Toosy Ahmed T; Jones Stephen J; Altmann Daniel R; Miszkiel Katharine A; MacManus David G; Barker Gareth J; Plant Gordon T; Thompson Alan J; Miller David H
A serial MRI study following optic nerve mean area in acute optic neuritis.
Brain : a journal of neurology 2004;127(Pt 11):2498-505.
2004: Cano Stefan J; Hobart Jeremy C; Fitzpatrick Ray; Bhatia Kailash; Thompson Alan J; Warner Thomas T
Patient-based outcomes of cervical dystonia: a review of rating scales.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):1054-9.
2004: Rashid W; Parkes L M; Ingle G T; Chard D T; Toosy A T; Altmann D R; Symms M R; Tofts P S; Thompson A J; Miller D H
Abnormalities of cerebral perfusion in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2004;75(9):1288-93.
2004: Chard D T; Griffin C M; Rashid W; Davies G R; Altmann D R; Kapoor R; Barker G J; Thompson A J; Miller D H
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):387-91.
2004: Hickman Simon J; Toosy Ahmed T; Miszkiel Katherine A; Jones Stephen J; Altmann Daniel R; MacManus David G; Plant Gordon T; Thompson Alan J; Miller David H
Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study.
Journal of neurology 2004;251(8):996-1005.
2004: Strens L H A; Asselman P; Pogosyan A; Loukas C; Thompson A J; Brown P
Corticocortical coupling in chronic stroke: its relevance to recovery.
Neurology 2004;63(3):475-84.
2004: Davies G R; Ramió-Torrentà L; Hadjiprocopis A; Chard D T; Griffin C M B; Rashid W; Barker G J; Kapoor R; Thompson A J; Miller D H
Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2004;75(7):998-1002.
2004: Miller David H; Leary Siobhan M; Thompson Alan J
Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10 Suppl 1():S56-7.
2004: Ward Nick S; Brown Martin M; Thompson Alan J; Frackowiak Richard S J
The influence of time after stroke on brain activations during a motor task.
Annals of neurology 2004;55(6):829-34.
2004: Fernando K T M; McLean M A; Chard D T; MacManus D G; Dalton C M; Miszkiel K A; Gordon R M; Plant G T; Thompson A J; Miller D H
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
Brain : a journal of neurology 2004;127(Pt 6):1361-9.
2004: O'Connor Rory J; Cano Stefan J; Thompson Alan J; Hobart Jeremy C
Exploring rating scale responsiveness: does the total score reflect the sum of its parts?
Neurology 2004;62(10):1842-4.
2004: Sastre-Garriga Jaume; Ingle Gordon T; Chard Declan T; Ramió-Torrentà Lluís; Miller David H; Thompson Alan J
Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis.
NeuroImage 2004;22(1):353-9.
2004: Dalton Catherine M; Chard Declan T; Davies Gerard R; Miszkiel Katherine A; Altmann Dan R; Fernando Kryshani; Plant Gordon T; Thompson Alan J; Miller David H
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.
Brain : a journal of neurology 2004;127(Pt 5):1101-7.
2004: Toosy Ahmed T; Ciccarelli Olga; Parker Geoff J M; Wheeler-Kingshott Claudia A M; Miller David H; Thompson Alan J
Characterizing function-structure relationships in the human visual system with functional MRI and diffusion tensor imaging.
NeuroImage 2004;21(4):1452-63.
2004: Edwards Simon G M; Thompson Alan J; Playford E Diane
Integrated care pathways: disease-specific or process-specific?
Clinical medicine (London, England) 2004;4(2):132-5.
2004: Hobart J C; Riazi A; Lamping D L; Fitzpatrick R; Thompson A J
Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
Health technology assessment (Winchester, England) 2004;8(9):iii, 1-48.
2004: Hickman S J; Toosy A T; Jones S J; Altmann D R; Miszkiel K A; MacManus D G; Barker G J; Plant G T; Thompson A J; Miller D H
Serial magnetization transfer imaging in acute optic neuritis.
Brain : a journal of neurology 2004;127(Pt 3):692-700.
2004: Riazi A; Thompson A J; Hobart J C
Self-efficacy predicts self-reported health status in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(1):61-6.
2004: Rashid W; Hadjiprocopis A; Griffin C M; Chard D T; Davies G R; Barker G J; Tofts P S; Thompson A J; Miller D H
Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(1):9-15.
2004: Lim Ee Tuan; Petzold Axel; Leary Siobhan M; Altmann Daniel R; Keir Geoff; Thompson Ed J; Miller David H; Thompson Alan J; Giovannoni Gavin
Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
Journal of negative results in biomedicine 2004;3():4.
2003: Miller D H; Thompson A J; Filippi M
Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis.
Journal of neurology 2003;250(12):1407-19.
2003: Kappos L; Polman C; Thompson A J; Duda P; Clanet M; Comi G; Hartung H P; Montalban X
Towards a european network for multiple sclerosis trials (ENMST).
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(6):627-9.
2003: Traboulsee A; Dehmeshki J; Peters Kevin R; Griffin C M; Brex P A; Silver N; Ciccarrelli O; Chard D T; Barker G J; Thompson A J; Miller D H
Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(6):566-73.
2003: Dalton C M; Brex P A; Miszkiel K A; Fernando K; MacManus D G; Plant G T; Thompson A J; Miller D H
Spinal cord MRI in clinically isolated optic neuritis.
Journal of neurology, neurosurgery, and psychiatry 2003;74(11):1577-80.
2003: Chard D T; Brex P A; Ciccarelli O; Griffin C M; Parker G J M; Dalton C; Altmann D R; Thompson A J; Miller D H
The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study.
Journal of neurology, neurosurgery, and psychiatry 2003;74(11):1551-4.
2003: Ward N S; Brown M M; Thompson A J; Frackowiak R S J
Neural correlates of motor recovery after stroke: a longitudinal fMRI study.
Brain : a journal of neurology 2003;126(Pt 11):2476-96.
2003: Ingle G T; Stevenson V L; Miller D H; Thompson A J
Primary progressive multiple sclerosis: a 5-year clinical and MR study.
Brain : a journal of neurology 2003;126(Pt 11):2528-36.
2003: Liu Clarence; Playford E Diane; Thompson Alan J
Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?
Journal of neurology 2003;250(10):1214-8.
2003: Porter B; Keenan E; Record E; Thompson A J
Diagnosis of MS: a comparison of three different clinical settings.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(5):431-9.
2003: Pryce Gareth; Ahmed Zubair; Hankey Deborah J R; Jackson Samuel J; Croxford J Ludovic; Pocock Jennifer M; Ledent Catherine; Petzold Axel; Thompson Alan J; Giovannoni Gavin; Cuzner M Louise; Baker David
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Brain : a journal of neurology 2003;126(Pt 10):2191-202.
2003: Riazi Afsane; Hobart Jeremy C; Fitzpatrick Ray; Freeman Jennifer A; Thompson Alan J
Socio-demographic variables are limited predictors of health status in multiple sclerosis.
Journal of neurology 2003;250(9):1088-93.
2003: Dubois Bénédicte; Leary Siobhan M; Nelissen Inge; Opdenakker Ghislain; Giovannoni Gavin; Thompson Alan J
Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
Journal of neurology 2003;250(9):1037-43.
2003: Hickman Simon J; Coulon Olivier; Parker Geoffrey J M; Barker Gareth J; Stevenson Valerie L; Chard Declan T; Arridge Simon R; Thompson Alan J; Miller David H
Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images.
Journal of magnetic resonance imaging : JMRI 2003;18(3):368-71.
2003: Toosy A T; Werring D J; Orrell R W; Howard R S; King M D; Barker G J; Miller D H; Thompson A J
Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2003;74(9):1250-7.
2003: Ciccarelli O; Toosy A T; Parker G J M; Wheeler-Kingshott C A M; Barker G J; Miller D H; Thompson A J
Diffusion tractography based group mapping of major white-matter pathways in the human brain.
NeuroImage 2003;19(4):1545-55.
2003: Riazi A; Hobart J C; Lamping D L; Fitzpatrick R; Thompson A J
Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(4):411-9.
2003: Dubois B D; Keenan E; Porter B E; Kapoor R; Rudge P; Thompson A J; Miller D H; Giovannoni G
Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre.
Journal of neurology, neurosurgery, and psychiatry 2003;74(7):946-9.
2003: Davies G R; Ramani A; Dalton C M; Tozer D J; Wheeler-Kingshott C A M; Barker G J; Thompson A J; Miller D H; Tofts P S
Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin?
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):246-9.
2003: Ward N S; Brown M M; Thompson A J; Frackowiak R S J
Neural correlates of outcome after stroke: a cross-sectional fMRI study.
Brain : a journal of neurology 2003;126(Pt 6):1430-48.
2003: Riazi A; Hobart J C; Lamping D L; Fitzpatrick R; Freeman J A; Jenkinson C; Peto V; Thompson A J
Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.
Journal of neurology, neurosurgery, and psychiatry 2003;74(6):710-4.
2003: Baker David; Pryce Gareth; Giovannoni Gavin; Thompson Alan J
The therapeutic potential of cannabis.
Lancet neurology 2003;2(5):291-8.
2003: Dalton Catherine M; Brex Peter A; Miszkiel Katherine A; Fernando Kryshani; MacManus David G; Plant Gordon T; Thompson Alan J; Miller David H
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes.
Annals of neurology 2003;53(5):673-6.
2003: Ciccarelli Olga; Werring David J; Barker Gareth J; Griffin Colette M; Wheeler-Kingshott Claudia A M; Miller David H; Thompson Alan J
A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration.
Journal of neurology 2003;250(3):287-92.
2003: Inglese M; van Waesberghe J H T M; Rovaris M; Beckmann K; Barkhof F; Hahn D; Kappos L; Miller D H; Polman C; Pozzilli C; Thompson A J; Yousry T A; Wagner K; Comi G; Filippi M
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.
Neurology 2003;60(5):853-60.
2003: Ciccarelli O; Parker G J M; Toosy A T; Wheeler-Kingshott C A M; Barker G J; Boulby P A; Miller D H; Thompson A J
From diffusion tractography to quantitative white matter tract measures: a reproducibility study.
NeuroImage 2003;18(2):348-59.
2003: Leary Siobhan M; Thompson Alan J
Interferon beta-1a in primary progressive multiple sclerosis.
Journal of the neurological sciences 2003;206(2):215-6.
2003: Leary S M; Miller D H; Stevenson V L; Brex P A; Chard D T; Thompson A J
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
Neurology 2003;60(1):44-51.
2003: Hobart J C; Riazi A; Lamping D L; Fitzpatrick R; Thompson A J
Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
Neurology 2003;60(1):31-6.
2002: Jarrett L; Nandi P; Thompson A J
Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role?
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):705-9.
2002: Riazi A; Hobart J C; Lamping D L; Fitzpatrick R; Thompson A J
Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):701-4.
2002: Chard D T; Griffin C M; McLean M A; Kapeller P; Kapoor R; Thompson A J; Miller D H
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
Brain : a journal of neurology 2002;125(Pt 10):2342-52.
2002: Toosy A T; Werring D J; Bullmore E T; Plant G T; Barker G J; Miller D H; Thompson A J
Functional magnetic resonance imaging of the cortical response to photic stimulation in humans following optic neuritis recovery.
Neuroscience letters 2002;330(3):255-9.
2002: Miller David H; Barkhof Frederik; Frank Joseph A; Parker Geoffrey J M; Thompson Alan J
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.
Brain : a journal of neurology 2002;125(Pt 8):1676-95.
2002: Garrard P; Bradshaw D; Jäger H R; Thompson A J; Losseff N; Playford D
Cognitive dysfunction after isolated brain stem insult. An underdiagnosed cause of long term morbidity.
Journal of neurology, neurosurgery, and psychiatry 2002;73(2):191-4.
2002: Dalton C M; Brex P A; Jenkins R; Fox N C; Miszkiel K A; Crum W R; O'Riordan J I; Plant G T; Thompson A J; Miller D H
Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2002;73(2):141-7.
2002: Dalton Catherine M; Brex Peter A; Miszkiel Katherine A; Hickman Simon J; MacManus David G; Plant Gordon T; Thompson Alan J; Miller David H
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis.
Annals of neurology 2002;52(1):47-53.
2002: Edwards S G M; Thompson A J; Losseff N; Playford E D
Shortening inpatient stay for stroke.
Lancet 2002;359(9324):2205.
2002: Edwards S G M; Playford E D; Hobart J C; Thompson A J
Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation.
BMJ (Clinical research ed.) 2002;324(7352):1493.
2002: Thompson Alan J
Progress in neurorehabilitation in multiple sclerosis.
Current opinion in neurology 2002;15(3):267-70.
2002: Griffin C M; Dehmeshki J; Chard D T; Parker G J M; Barker G J; Thompson A J; Miller D H
T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(3):211-6.
2002: Kapeller P; Brex P A; Chard D; Dalton C; Griffin C M; McLean M A; Parker G J M; Thompson A J; Miller D H
Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(3):207-10.
2002: Hobart Jeremy C; Williams Linda S; Moran Kimberly; Thompson Alan J
Quality of life measurement after stroke: uses and abuses of the SF-36.
Stroke; a journal of cerebral circulation 2002;33(5):1348-56.
2002: Ingle G T; Stevenson V L; Miller D H; Leary S M; Rovaris M; Barkhof F; Brochet B; Dousset V; Filippi M; Montalban X; Kalkers N F; Polman C H; Rovira A; Thompson A J
Two-year follow-up study of primary and transitional progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):108-14.
2002: Ingle Gordon T; Thompson Alan J; Miller David H
Magnetic resonance imaging in primary progressive multiple sclerosis.
Journal of rehabilitation research and development 2002;39(2):261-71.
2002: Chard Declan T; Parker Geoffrey J M; Griffin Colette M B; Thompson Alan J; Miller David H
The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.
Journal of magnetic resonance imaging : JMRI 2002;15(3):259-67.
2002: Griffin Colette M; Chard Declan T; Parker Geoff J M; Barker Gareth J; Thompson Alan J; Miller David H
The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
Journal of neurology 2002;249(2):193-9.
2002: Stevenson Valerie L; Smith Stephen M; Matthews Paul M; Miller David H; Thompson Alan J
Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
Journal of neurology 2002;249(2):171-7.
2002: Chard D T; Griffin C M; Parker G J M; Kapoor R; Thompson A J; Miller D H
Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
Brain : a journal of neurology 2002;125(Pt 2):327-37.
2002: Ciccarelli Olga; Brex Peter A; Thompson Alan J; Miller David H
Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR.
Journal of neurology 2002;249(1):18-24.
2002: Brex Peter A; Ciccarelli Olga; O'Riordan Jonathon I; Sailer Michael; Thompson Alan J; Miller David H
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.
The New England journal of medicine 2002;346(3):158-64.
2001: Molyneux P D; Barker G J; Barkhof F; Beckmann K; Dahlke F; Filippi M; Ghazi M; Hahn D; MacManus D; Polman C; Pozzilli C; Kappos L; Thompson A J; Wagner K; Yousry T; Miller D H;
Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.
Neurology 2001;57(12):2191-7.
2001: Brex P A; Molyneux P D; Smiddy P; Barkhof F; Filippi M; Yousry T A; Hahn D; Rolland Y; Salonen O; Pozzilli C; Polman C H; Thompson A J; Kappos L; Miller D H;
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.
Neurology 2001;57(12):2185-90.
2001: Thompson A J
Symptomatic management and rehabilitation in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2001;71 Suppl 2():ii22-7.
2001: Freeman J A; Thompson A J; Fitzpatrick R; Hutchinson M; Miltenburger C; Beckmann K; Dahlke F; Kappos L; Polman C; Pozzilli C;
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life.
Neurology 2001;57(10):1870-5.
2001: Toosy A T; Werring D J; Plant G T; Bullmore E T; Miller D H; Thompson A J
Asymmetrical activation of human visual cortex demonstrated by functional MRI with monocular stimulation.
NeuroImage 2001;14(3):632-41.
2001: Camp S J; Thompson A J; Langdon D W
A new test of memory for multiple sclerosis I: format development and stimuli design.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(4):255-62.
2001: Giovannoni G; Thompson A J; Miller D H; Thompson E J
Fatigue is not associated with raised inflammatory markers in multiple sclerosis.
Neurology 2001;57(4):676-81.
2001: Hobart J C; Lamping D L; Freeman J A; Langdon D W; McLellan D L; Greenwood R J; Thompson A J
Evidence-based measurement: which disability scale for neurologic rehabilitation?
Neurology 2001;57(4):639-44.
2001: Hobart J C; Thompson A J
The five item Barthel index.
Journal of neurology, neurosurgery, and psychiatry 2001;71(2):225-30.
2001: Freeman J A; Hobart J C; Thompson A J
Does adding MS-specific items to a generic measure (the SF-36) improve measurement?
Neurology 2001;57(1):68-74.
2001: Barkhof F; van Waesberghe J H; Filippi M; Yousry T; Miller D H; Hahn D; Thompson A J; Kappos L; Brex P; Pozzilli C; Polman C H;
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment.
Brain : a journal of neurology 2001;124(Pt 7):1396-402.
2001: Losseff N A; Wang L; Miller D H; Thompson A J
T1 hypointensity of the spinal cord in multiple sclerosis.
Journal of neurology 2001;248(6):517-21.
2001: Giovannoni G; Miller D H; Losseff N A; Sailer M; Lewellyn-Smith N; Thompson A J; Thompson E J
Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis.
Journal of neurology 2001;248(6):487-95.
2001: Werring D J; Clark C A; Droogan A G; Barker G J; Miller D H; Thompson A J
Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(2):83-9.
2001: Silver N C; Tofts P S; Symms M R; Barker G J; Thompson A J; Miller D H
Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(2):75-82.
2001: Ciccarelli O; Werring D J; Wheeler-Kingshott C A; Barker G J; Parker G J; Thompson A J; Miller D H
Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.
Neurology 2001;56(7):926-33.
2001: Brex P A; Leary S M; O'Riordan J I; Miszkiel K A; Plant G T; Thompson A J; Miller D H
Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2001;70(4):544-7.
2001: Silver N C; Good C D; Sormani M P; MacManus D G; Thompson A J; Filippi M; Miller D H
A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis.
Journal of neurology 2001;248(3):215-24.
2001: Dehmeshki J; Silver N C; Leary S M; Tofts P S; Thompson A J; Miller D H
Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups.
Journal of the neurological sciences 2001;185(1):11-7.
2001: Brex P A; Miszkiel K A; O'Riordan J I; Plant G T; Moseley I F; Thompson A J; Miller D H
Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI.
Journal of neurology, neurosurgery, and psychiatry 2001;70(3):390-3.
2001: Losseff N A; Miller D H; Kidd D; Thompson A J
The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis--preliminary results.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(1):23-5.
2001: Kapeller P; McLean M A; Griffin C M; Chard D; Parker G J; Barker G J; Thompson A J; Miller D H
Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study.
Journal of neurology 2001;248(2):131-8.
2001: Thompson A J; Playford E D
Rehabilitation for patients with Parkinson's disease.
Lancet 2001;357(9254):410-1.
2000: Freeman J A; Thompson A J
Community services in multiple sclerosis: still a matter of chance.
Journal of neurology, neurosurgery, and psychiatry 2000;69(6):728-32.
2000: Thompson A J
Neurological rehabilitation: from mechanisms to management.
Journal of neurology, neurosurgery, and psychiatry 2000;69(6):718-22.
2000: Molyneux P D; Kappos L; Polman C; Pozzilli C; Barkhof F; Filippi M; Yousry T; Hahn D; Wagner K; Ghazi M; Beckmann K; Dahlke F; Losseff N; Barker G J; Thompson A J; Miller D H
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.
Brain : a journal of neurology 2000;123 ( Pt 11)():2256-63.
2000: Griffin C M; Parker G J; Barker G J; Thompson A J; Miller D H
MTR and T1 provide complementary information in MS NAWM, but not in lesions.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(5):327-31.
2000: Stevenson V L; Parker G J; Barker G J; Birnie K; Tofts P S; Miller D H; Thompson A J
Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis.
Journal of the neurological sciences 2000;178(2):81-7.
2000: Lazeron R H; Langdon D W; Filippi M; van Waesberghe J H; Stevenson V L; Boringa J B; Origgi D; Thompson A J; Falautano M; Polman C H; Barkhof F
Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(4):280-5.
2000: Werring D J; Brassat D; Droogan A G; Clark C A; Symms M R; Barker G J; MacManus D G; Thompson A J; Miller D H
The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study.
Brain : a journal of neurology 2000;123 ( Pt 8)():1667-76.
2000: Werring D J; Toosy A T; Clark C A; Parker G J; Barker G J; Miller D H; Thompson A J
Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke.
Journal of neurology, neurosurgery, and psychiatry 2000;69(2):269-72.
2000: Thompson A J; Montalban X; Barkhof F; Brochet B; Filippi M; Miller D H; Polman C H; Stevenson V L; McDonald W I
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
Annals of neurology 2000;47(6):831-5.
2000: Stevenson V L; Miller D H; Leary S M; Rovaris M; Barkhof F; Brochet B; Dousset V; Filippi M; Hintzen R; Montalban X; Polman C H; Rovira A; de Sa J; Thompson A J
One year follow up study of primary and transitional progressive multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2000;68(6):713-8.
2000: Leary S M; Brex P A; MacManus D G; Parker G J; Barker G J; Miller D H; Thompson A J
A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis.
Magnetic resonance imaging 2000;18(4):455-9.
2000: Brex P A; Parker G J; Leary S M; Molyneux P D; Barker G J; Davie C A; Thompson A J; Miller D H
Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations.
Journal of neurology, neurosurgery, and psychiatry 2000;68(5):627-32.
2000: Werring D J; Bullmore E T; Toosy A T; Miller D H; Barker G J; MacManus D G; Brammer M J; Giampietro V P; Brusa A; Brex P A; Moseley I F; Plant G T; McDonald W I; Thompson A J
Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study.
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):441-9.
2000: Foong J; Rozewicz L; Chong W K; Thompson A J; Miller D H; Ron M A
A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis.
Journal of neurology 2000;247(2):97-101.
2000: Fox N C; Jenkins R; Leary S M; Stevenson V L; Losseff N A; Crum W R; Harvey R J; Rossor M N; Miller D H; Thompson A J
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI.
Neurology 2000;54(4):807-12.
2000: Freeman J A; Hobart J C; Langdon D W; Thompson A J
Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2000;68(2):150-6.
1999: Davie C A; Silver N C; Barker G J; Tofts P S; Thompson A J; McDonald W I; Miller D H
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?
Journal of neurology, neurosurgery, and psychiatry 1999;67(6):710-5.
1999: Leary S M; Davie C A; Parker G J; Stevenson V L; Wang L; Barker G J; Miller D H; Thompson A J
1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis.
Journal of neurology 1999;246(11):1023-6.
1999: van Waesberghe J H; Kamphorst W; De Groot C J; van Walderveen M A; Castelijns J A; Ravid R; Lycklama à Nijeholt G J; van der Valk P; Polman C H; Thompson A J; Barkhof F
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.
Annals of neurology 1999;46(5):747-54.
1999: Grimaud J; Barker G J; Wang L; Lai M; MacManus D G; Webb S L; Thompson A J; McDonald W I; Tofts P S; Miller D H
Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study.
Journal of neurology 1999;246(10):961-7.
1999: Brex P A; O'Riordan J I; Miszkiel K A; Moseley I F; Thompson A J; Plant G T; Miller D H
Multisequence MRI in clinically isolated syndromes and the early development of MS.
Neurology 1999;53(6):1184-90.
1999: Leary S M; Silver N C; Stevenson V L; Barker G J; Miller D H; Thompson A J
Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(5):313-6.
1999: Thompson A J
Measuring handicap in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(4):260-2.
1999: Leary S M; Stevenson V L; Miller D H; Thompson A J
Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis.
Journal of neurology 1999;246(7):562-8.
1999: Camp S J; Stevenson V L; Thompson A J; Miller D H; Borras C; Auriacombe S; Brochet B; Falautano M; Filippi M; Hérissé-Dulo L; Montalban X; Parrcira E; Polman C H; De Sa J; Langdon D W
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.
Brain : a journal of neurology 1999;122 ( Pt 7)():1341-8.
1999: Leary S M; Parker G J; Stevenson V L; Barker G J; Miller D H; Thompson A J
Reproducibility of magnetic resonance imaging measurements of spinal cord atrophy: the role of quality assurance.
Magnetic resonance imaging 1999;17(5):773-6.
1999: Werring D J; Clark C A; Barker G J; Thompson A J; Miller D H
Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis.
Neurology 1999;52(8):1626-32.
1999: Langdon D W; Thompson A J
Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome.
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(2):94-100.
1999: van der Putten J J; Hobart J C; Freeman J A; Thompson A J
Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure.
Journal of neurology, neurosurgery, and psychiatry 1999;66(4):480-4.
1999: Stevenson V L; Miller D H; Rovaris M; Barkhof F; Brochet B; Dousset V; Dousset V; Filippi M; Montalban X; Polman C H; Rovira A; de Sa J; Thompson A J
Primary and transitional progressive MS: a clinical and MRI cross-sectional study.
Neurology 1999;52(4):839-45.
1999: Werring D J; Clark C A; Parker G J; Miller D H; Thompson A J; Barker G J
A direct demonstration of both structure and function in the visual system: combining diffusion tensor imaging with functional magnetic resonance imaging.
NeuroImage 1999;9(3):352-61.
1999: Sailer M; O'Riordan J I; Thompson A J; Kingsley D P; MacManus D G; McDonald W I; Miller D H
Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination.
Neurology 1999;52(3):599-606.
1999: Freeman J A; Langdon D W; Hobart J C; Thompson A J
Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?
Neurology 1999;52(1):50-6.
1999: Richardson D; Thompson A J
Management of spasticity in hereditary spastic paraplegia.
Physiotherapy research international : the journal for researchers and clinicians in physical therapy 1999;4(1):68-76.
1999: Foong J; Rozewicz L; Davie C A; Thompson A J; Miller D H; Ron M A
Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology.
The Journal of neuropsychiatry and clinical neurosciences 1999;11(1):45-50.
1998: Werring D J; Clark C A; Barker G J; Miller D H; Parker G J; Brammer M J; Bullmore E T; Giampietro V P; Thompson A J
The structural and functional mechanisms of motor recovery: complementary use of diffusion tensor and functional magnetic resonance imaging in a traumatic injury of the internal capsule.
Journal of neurology, neurosurgery, and psychiatry 1998;65(6):863-9.
1998: Thompson A J
Symptomatic treatment in multiple sclerosis.
Current opinion in neurology 1998;11(4):305-9.
1998: Stevenson V L; Moseley I F; Phatouros C C; MacManus D; Thompson A J; Miller D H
Improved imaging of the spinal cord in multiple sclerosis using three-dimensional fast spin echo.
Neuroradiology 1998;40(7):416-9.
1998: Stevenson V L; Leary S M; Losseff N A; Parker G J; Barker G J; Husmani Y; Miller D H; Thompson A J
Spinal cord atrophy and disability in MS: a longitudinal study.
Neurology 1998;51(1):234-8.
1998: Thompson A J
Identification of brain atrophy with MRI in MS.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):257-9.
1998: Rossiter D A; Edmondson A; al-Shahi R; Thompson A J
Integrated care pathways in multiple sclerosis rehabilitation: completing the audit cycle.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(2):85-9.
1998: Thompson A J; Hobart J C
Multiple sclerosis: assessment of disability and disability scales.
Journal of neurology 1998;245(4):189-96.
1998: Foong J; Rozewicz L; Quaghebeur G; Thompson A J; Miller D H; Ron M A
Neuropsychological deficits in multiple sclerosis after acute relapse.
Journal of neurology, neurosurgery, and psychiatry 1998;64(4):529-32.
1998: O'Riordan J I; Thompson A J; Kingsley D P; MacManus D G; Kendall B E; Rudge P; McDonald W I; Miller D H
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.
Brain : a journal of neurology 1998;121 ( Pt 3)():495-503.
1998: O'Riordan J I; Losseff N A; Phatouros C; Thompson A J; Moseley I F; MacManus D G; McDonald W I; Miller D H
Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination.
Journal of neurology, neurosurgery, and psychiatry 1998;64(3):353-7.
1998: Tubridy N; Coles A J; Molyneux P; Compston D A; Barkhof F; Thompson A J; McDonald W I; Miller D H
Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.
Brain : a journal of neurology 1998;121 ( Pt 2)():225-31.
1998: Gawne-Cain M L; O'Riordan J I; Coles A; Newell B; Thompson A J; Miller D H
MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):197-203.
1998: Tubridy N; Ader H J; Barkhof F; Thompson A J; Miller D H
Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups.
Journal of neurology, neurosurgery, and psychiatry 1998;64(1):50-5.
1997: Davie C A; Barker G J; Thompson A J; Tofts P S; McDonald W I; Miller D H
1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1997;63(6):736-42.
1997: Richardson D; Edwards S; Sheean G L; Greenwood R J; Thompson A J
The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5/6: a case report.
Clinical rehabilitation 1997;11(4):288-92.
1997: Wang L; Lai H M; Thompson A J; Miller D H
Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load.
Journal of neurology, neurosurgery, and psychiatry 1997;63(4):452-5.
1997: Gawne-Cain M L; O'Riordan J I; Thompson A J; Moseley I F; Miller D H
Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo.
Neurology 1997;49(2):364-70.
1997: van Oosten B W; Lai M; Hodgkinson S; Barkhof F; Miller D H; Moseley I F; Thompson A J; Rudge P; McDougall A; McLeod J G; Adèr H J; Polman C H
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial.
Neurology 1997;49(2):351-7.
1997: Freeman J A; Langdon D W; Hobart J C; Thompson A J
The impact of inpatient rehabilitation on progressive multiple sclerosis.
Annals of neurology 1997;42(2):236-44.
1997: Silver N C; Good C D; Barker G J; MacManus D G; Thompson A J; Moseley I F; McDonald W I; Miller D H
Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
Brain : a journal of neurology 1997;120 ( Pt 7)():1149-61.
1997: Silver N C; Barker G J; Losseff N A; Gawne-Cain M L; MacManus D G; Thompson A J; Miller D H
Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis.
Neuroradiology 1997;39(6):441-5.
1997: Thompson A J; Polman C H; Miller D H; McDonald W I; Brochet B; Filippi M Montalban X; De Sá J
Primary progressive multiple sclerosis.
Brain : a journal of neurology 1997;120 ( Pt 6)():1085-96.
1997: Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson A J; Miller D H; Feldmann M; Thompson E J
Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
Neurology 1997;48(6):1557-65.
1997: Lai H M; Davie C A; Gass A; Barker G J; Webb S; Tofts P S; Thompson A J; McDonald W I; Miller D H
Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis.
Journal of neurology 1997;244(5):308-11.
1997: Stevenson V L; Gawne-Cain M L; Barker G J; Thompson A J; Miller D H
Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo.
Journal of neurology 1997;244(2):119-24.
1997: Foong J; Rozewicz L; Quaghebeur G; Davie C A; Kartsounis L D; Thompson A J; Miller D H; Ron M A
Executive function in multiple sclerosis. The role of frontal lobe pathology.
Brain : a journal of neurology 1997;120 ( Pt 1)():15-26.
1997: Giovannoni G; Lai M; Kidd D; Thorpe J W; Miller D H; Thompson A J; Keir G; Feldmann M; Thompson E J
Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis.
Brain : a journal of neurology 1997;120 ( Pt 1)():1-13.
1996: Losseff N A; Wang L; Lai H M; Yoo D S; Gawne-Cain M L; McDonald W I; Miller D H; Thompson A J
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.
Brain : a journal of neurology 1996;119 ( Pt 6)():2009-19.
1996: Stevenson V L; Playford E D; Langdon D W; Thompson A J
Rehabilitation of incomplete spinal cord pathology: factors affecting prognosis and outcome.
Journal of neurology 1996;243(9):644-7.
1996: Thompson A J
Multiple sclerosis: symptomatic treatment.
Journal of neurology 1996;243(8):559-65.
1996: Rovaris M; Barnes D; Woodrofe N; du Boulay G H; Thorpe J W; Thompson A J; McDonald W I; Miller D H
Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.
Journal of neurology 1996;243(7):536-42.
1996: Gasperini C; Horsfield M A; Thorpe J W; Kidd D; Barker G J; Tofts P S; MacManus D G; Thompson A J; Miller D H; McDonald W I
Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters.
Journal of magnetic resonance imaging : JMRI 1996;6(4):580-4.
1996: Thompson A J; Noseworthy J H
New treatments for multiple sclerosis: a clinical perspective.
Current opinion in neurology 1996;9(3):187-98.
1996: Thorpe J W; Kidd D; Moseley I F; Thompson A J; MacManus D G; Compston D A; McDonald W I; Miller D H
Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI.
Brain : a journal of neurology 1996;119 ( Pt 3)():709-14.
1996: Losseff N A; Webb S L; O'Riordan J I; Page R; Wang L; Barker G J; Tofts P S; McDonald W I; Miller D H; Thompson A J
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.
Brain : a journal of neurology 1996;119 ( Pt 3)():701-8.
1996: O'Riordan J I; Gallagher H L; Thompson A J; Howard R S; Kingsley D P; Thompson E J; McDonald W I; Miller D H
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.
Journal of neurology, neurosurgery, and psychiatry 1996;60(4):382-7.
1996: Lai M; Hodgson T; Gawne-Cain M; Webb S; MacManus D; McDonald W I; Thompson A J; Miller D H
A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1996;60(3):339-41.
1996: Losseff N A; Kingsley D P; McDonald W I; Miller D H; Thompson A J
Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(4):218-22.
1996: Hobart J C; Lamping D L; Thompson A J
Evaluating neurological outcome measures: the bare essentials.
Journal of neurology, neurosurgery, and psychiatry 1996;60(2):127-30.
1996: Thorpe J W; Kidd D; Moseley I F; Kenndall B E; Thompson A J; MacManus D G; McDonald W I; Miller D H
Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.
Neurology 1996;46(2):373-8.
1996: Freeman J A; Playford E D; Nicholas R S; Thompson A J
A neurological rehabilitation unit: audit of activity and outcome.
Journal of the Royal College of Physicians of London 1996;30(1):21-6.
1996: Giovannoni G; Thorpe J W; Kidd D; Kendall B E; Moseley I F; Thompson A J; Keir G; Miller D H; Feldmann M; Thompson E J
Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.
Journal of neurology, neurosurgery, and psychiatry 1996;60(1):20-6.
1996: Kidd D; Thorpe J W; Kendall B E; Barker G J; Miller D H; McDonald W I; Thompson A J
MRI dynamics of brain and spinal cord in progressive multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1996;60(1):15-9.
1995: Davie C A; Barker G J; Webb S; Tofts P S; Thompson A J; Harding A E; McDonald W I; Miller D H
Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.
Brain : a journal of neurology 1995;118 ( Pt 6)():1583-92.
1995: Jones S J; Turano G; Kriss A; Shawkat F; Kendall B; Thompson A J
Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.
Journal of neurology, neurosurgery, and psychiatry 1995;59(3):260-5.
1995: Filippi M; Paty D W; Kappos L; Barkhof F; Compston D A; Thompson A J; Zhao G J; Wiles C M; McDonald W I; Miller D H
Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.
Neurology 1995;45(2):255-60.
1994: Revesz T; Kidd D; Thompson A J; Barnard R O; McDonald W I
A comparison of the pathology of primary and secondary progressive multiple sclerosis.
Brain : a journal of neurology 1994;117 ( Pt 4)():759-65.
1994: Gass A; Barker G J; Kidd D; Thorpe J W; MacManus D; Brennan A; Tofts P S; Thompson A J; McDonald W I; Miller D H
Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis.
Annals of neurology 1994;36(1):62-7.
1994: McDonald W I; Miller D H; Thompson A J
Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
Annals of neurology 1994;36(1):14-8.
1994: Zoukos Y; Kidd D; Woodroofe M N; Kendall B E; Thompson A J; Cuzner M L
Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis.
Brain : a journal of neurology 1994;117 ( Pt 2)():307-15.
1994: Filippi M; Barker G J; Horsfield M A; Sacares P R; MacManus D G; Thompson A J; Tofts P S; McDonald W I; Miller D H
Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.
Journal of neurology 1994;241(4):246-51.
1993: Thompson A J; Kermode A G; Moseley I F; MacManus D G; McDonald W I
Seizures due to multiple sclerosis: seven patients with MRI correlations.
Journal of neurology, neurosurgery, and psychiatry 1993;56(12):1317-20.
1993: Kidd D; Thorpe J W; Thompson A J; Kendall B E; Moseley I F; MacManus D G; McDonald W I; Miller D H
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis.
Neurology 1993;43(12):2632-7.
1993: Thorpe J W; Kidd D; Kendall B E; Tofts P S; Barker G J; Thompson A J; MacManus D G; McDonald W I; Miller D H
Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults.
Neurology 1993;43(12):2625-31.
1992: Miller D H; Thompson A J; Morrissey S P; MacManus D G; Moore S G; Kendall B E; Moseley I F; McDonald W I
High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.
Journal of neurology, neurosurgery, and psychiatry 1992;55(6):450-3.
1992: Zoukos Y; Leonard J P; Thomaides T; Thompson A J; Cuzner M L
beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1.
Annals of neurology 1992;31(6):657-62.
1992: Thompson A J; Miller D; Youl B; MacManus D; Moore S; Kingsley D; Kendall B; Feinstein A; McDonald W I
Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.
Neurology 1992;42(1):60-3.
1991: Wroe S J; Thompson A J; McDonald W I
Painful intraorbital meningiomas.
Journal of neurology, neurosurgery, and psychiatry 1991;54(11):1009-10.
1991: Miller D H; Barkhof F; Berry I; Kappos L; Scotti G; Thompson A J
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.
Journal of neurology, neurosurgery, and psychiatry 1991;54(8):683-8.
1991: Thompson A J; Smith I; Kendall B E; Youl B D; Brenton D
Magnetic resonance imaging changes in early treated patients with phenylketonuria.
Lancet 1991;337(8751):1224.
1991: Youl B D; Kermode A G; Thompson A J; Révész T; Scaravilli F; Barnard R O; Kirkham F J; Kendall B E; Kingsley D; Moseley I F
Destructive lesions in demyelinating disease.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):288-92.
1991: Thompson A J; Kermode A G; Wicks D; MacManus D G; Kendall B E; Kingsley D P; McDonald W I
Major differences in the dynamics of primary and secondary progressive multiple sclerosis.
Annals of neurology 1991;29(1):53-62.
1990: Kermode A G; Rudge P; Thompson A J; du Boulay E P; McDonald W I
MRI of thoracic cord in tropical spastic paraparesis.
Journal of neurology, neurosurgery, and psychiatry 1990;53(12):1110-1.
1990: Kermode A G; Thompson A J; Tofts P; MacManus D G; Kendall B E; Kingsley D P; Moseley I F; Rudge P; McDonald W I
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.
Brain : a journal of neurology 1990;113 ( Pt 5)():1477-89.
1990: Thompson A J; Smith I; Brenton D; Youl B D; Rylance G; Davidson D C; Kendall B; Lees A J
Neurological deterioration in young adults with phenylketonuria.
Lancet 1990;336(8715):602-5.
1990: Thompson A J; Kermode A G; MacManus D G; Kendall B E; Kingsley D P; Moseley I F; McDonald W I
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
BMJ (Clinical research ed.) 1990;300(6725):631-4.
1990: Kermode A G; Tofts P S; Thompson A J; MacManus D G; Rudge P; Kendall B E; Kingsley D P; Moseley I F; du Boulay E P; McDonald W I
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
Neurology 1990;40(2):229-35.
1989: Thompson A J; Kermode A G; MacManus D G; Kingsley D P; Kendall B E; Moseley I F; McDonald W I
Pathogenesis of progressive multiple sclerosis.
Lancet 1989;1(8650):1322-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Alan Thompson

Research Profile (preview)

Disorders

Concepts & Ideas

Anatomy

Procedures

Physiology

Activities & Behaviors

Phenomena

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Alan Thompson (preview)

All Publications